Senior Director, RCC, Asset Team Leader, Late Phase Strategy, Development, Submissions & Lifecycle Management

Org Marketing Statement

All over the world, Pfizer colleagues are working together to positively impact health for everyone, everywhere. Each position at Pfizer touches and contributes to the success of our business and our world. That's why, as one of the global leaders in the biopharmaceutical industry, Pfizer is committed to seeking out inspired new talent who share our core values and mission of making the world a healthier place.

Role Description

Reporting to the Vice President , Late Phase Strategy, Development, Submissions and Lifecycle Management Group , this leadership position is accountable for driving the strategy, implementation and successful delivery of the Integrated Asset Plan for one or more of the late phase assets in the Pfizer Oncology portfolio. The Asset/Team Leader (A/TL) leads the global cross functional Asset team/s and is the single point of accountability for the seamless execution of project deliverables and decisions across a late phase or portfolio of assets in a timely, cost-effective and quality manner. The Asset Team includes colleagues from Clinical Development, Medical Affairs, Commercial Development, Global Health and Value, Regulatory, Finance, Statistics, Clinical Pharmacology, Translational Oncology, Pharmaceutical Sciences, Project Management and Development Operations. The A/TL will be responsible for informing and ensuring alignment of the asset strategy with key partners across the Pfizer Oncology Enterprise including but not limited to Pfizer Oncology, Worldwide Commercial Development (WWCD), and Pfizer's Worldwide Research & Development (WWRD) and Business Development (BD) Groups as appropriate.

For products within the Pfizer Oncology late phase portfolio, the A/TL is responsible for overseeing studies spanning from pivotal/proof-of-concept to registration-enabling studies, submissions, and post-approval life-cycle management through loss of exclusivity.

The A/TL is accountable for budget development and critical oversight and for recommending individual asset investment opportunities that will support investment prioritization in the context of the overall Pfizer Oncology portfolio.

The A/TL will be responsible for continuous optimization and refinement of the Asset strategy. The A/TL will also be responsible for approval of program and/or project plans as well as changes to the programs that impact the approved budget.

The A/TL applies oncology drug development knowledge and experience to assure that the asset is managed in an efficient and rigorous manner as reflected in the design and conduct of studies with high likelihood of technical, regulatory and commercial success. The A/TL will be an experienced people leader and will be responsible for optimizing team alignment, governance and overall team health.

The A/TL will be a decisive leader who can apply cost effective, time efficient and high quality approaches to drug development, submissions and lifecycle management.

Responsibilities

This position will report to the VP Late Phase Strategy, Development, Submissions and Lifecycle Management Group Leader

Current Late Phase strategic priorities include:

* Leading the strategy, development and implementation of the Integrated asset (or asset portfolio) plan

* Leading lifecycle strategy and planning for the asset and /or franchise plans that will deliver the greatest value for each asset to patients worldwide, physicians, payors and Pfizer

* Leading collaborations with world experts (including other companies where appropriate) to ensure optimization of the Pfizer oncology strategy and pipeline

* Working with Oncology Enterprise leadership across Pfizer to ensure alignment of appropriate technologies, capabilities, talent and resources to support the oncology portfolio

* Ensuring teams navigate programs toward rapid decisions

* Specific Duties of the A/TL role:

1.Leads and is responsible for directing a cross functional Asset Team(s)

2. Accountable for developing and delivering the Integrated Asset Plan, and ensuring that the Integrated Asset Plan is consistent with Pfizer Oncology Strategy

3. Accountable for assuring that projects are managed cost-effectively per budget, and looks to de-risk the candidate and investments as early as practical

4. Accountable for ensuring that the necessary resources are applied to the project team to support its success

5. Assures for the quality of asset deliverables to external health authorities

6. Promotes a culture of innovation and collaboration within the cross-functional team(s) in order to bring forward creative, defensible development plans that maximize the potential of each asset

7. Acts as point of contact and project representative to governance and other decision-making bodies, including information dissemination and the resolution of critical project issues

8. Leverages line expertise to achieve the team goals

9. Has an appropriate role representing and leading Pfizer Oncology in asset-based development partnerships and alliances

10. Able to engage with Business Development and contribute to efforts to optimize the late phase oncology portfolio though in-licensing, co-sponsorship, and other collaborative efforts

11. Negotiates and influences key internal stakeholders

12. Creates a motivated, committed and engaged project team

13. Models and expects effective team behavior to achieve the project goals

14. Manages key interdivisional interfaces on project issues with line functions.

Qualifications

* Graduate with post-graduate training in biomedical sciences or one of the disciplines related to drug development

* Proven ability to function effectively across a complex matrix organization with multiple

stakeholders and constituents, with the ability and gravitas to align a team to work towards a singular goal

* Minimum of 15 years of relevant experience in the pharmaceutical, academic and/or medical research environments having successfully executed a major component of a development program.

Significant Phase 1-3 clinical research experience with strong understanding of the elements of drug development programs and experience in their design, execution, and submission.

* An organized, independent, self-motivated individual with exceptional presentation, written, and oral communication skills

* Able to tailor presentations to the knowledge level of the audience to suit their needs and maximize understanding of the topic

* At least five years of experience in Oncology Drug Development

* Proven track record of success in an Oncology and Drug Development Team environment

Prior Experience Preferred:

* Experience in late phase clinical development for oncology

* Demonstrated experience in successfully leading teams, running them effectively, efficiently and on target. Capable of recognizing when team interventions and escalations are required to enhance team effectiveness

* Significant experience leading late stage clinical development studies, programs and clinical operations

* Direct experience in preparation of regulatory submissions, presentation to regulatory advisory panels in support of registration of a new drug

* Knowledgeable of the commercial and environmental issues that drive drug development projects

EEO & Employment Eligibility

Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.